ArticleOncoimmunology

Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN).

Antonela Merlotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.